1. Home
  2. ETJ vs UPB Comparison

ETJ vs UPB Comparison

Compare ETJ & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETJ
  • UPB
  • Stock Information
  • Founded
  • ETJ 2007
  • UPB 2021
  • Country
  • ETJ United States
  • UPB United States
  • Employees
  • ETJ N/A
  • UPB N/A
  • Industry
  • ETJ Finance Companies
  • UPB
  • Sector
  • ETJ Finance
  • UPB
  • Exchange
  • ETJ Nasdaq
  • UPB NYSE
  • Market Cap
  • ETJ 603.7M
  • UPB 823.6M
  • IPO Year
  • ETJ N/A
  • UPB 2024
  • Fundamental
  • Price
  • ETJ $8.87
  • UPB $15.54
  • Analyst Decision
  • ETJ
  • UPB Strong Buy
  • Analyst Count
  • ETJ 0
  • UPB 4
  • Target Price
  • ETJ N/A
  • UPB $56.50
  • AVG Volume (30 Days)
  • ETJ 175.6K
  • UPB 452.4K
  • Earning Date
  • ETJ 01-01-0001
  • UPB 08-14-2025
  • Dividend Yield
  • ETJ 8.30%
  • UPB N/A
  • EPS Growth
  • ETJ N/A
  • UPB N/A
  • EPS
  • ETJ N/A
  • UPB N/A
  • Revenue
  • ETJ N/A
  • UPB $2,296,000.00
  • Revenue This Year
  • ETJ N/A
  • UPB N/A
  • Revenue Next Year
  • ETJ N/A
  • UPB N/A
  • P/E Ratio
  • ETJ N/A
  • UPB N/A
  • Revenue Growth
  • ETJ N/A
  • UPB N/A
  • 52 Week Low
  • ETJ $7.20
  • UPB $5.14
  • 52 Week High
  • ETJ $8.47
  • UPB $29.46
  • Technical
  • Relative Strength Index (RSI)
  • ETJ 44.31
  • UPB N/A
  • Support Level
  • ETJ $8.91
  • UPB N/A
  • Resistance Level
  • ETJ $9.03
  • UPB N/A
  • Average True Range (ATR)
  • ETJ 0.09
  • UPB 0.00
  • MACD
  • ETJ -0.01
  • UPB 0.00
  • Stochastic Oscillator
  • ETJ 22.73
  • UPB 0.00

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

Share on Social Networks: